CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech
MONROE, Ohio, May 22, 2023 /PRNewswire/ — CSafe, the largest provider of a complete range of active and passive temperature-controlled
Read MoreMONROE, Ohio, May 22, 2023 /PRNewswire/ — CSafe, the largest provider of a complete range of active and passive temperature-controlled
Read MoreFirst patient dosed with CK0803 Treg cells for treatment of amyotrophic lateral sclerosis (ALS). Ongoing Phase 1/1b study evaluating safety
Read More– Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication – NEWTON, Mass. and FLORENCE, Italy, Feb.
Read MoreSEOUL, South Korea, Jan. 26, 2023 /PRNewswire/ — GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, announced that it has entered
Read MoreMONTREAL, Jan. 18, 2023 /PRNewswire/ — To ensure patient safety remains at the forefront of the work of the World
Read MoreIntegration of CTC (Circulating Tumor Cell) enumeration* to decide between endocrine therapy and chemotherapy may lead to improved clinical outcomes
Read More– Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related
Read MoreST. PAUL, Minn., Oct. 13, 2022 /PRNewswire/ — 3M Health Care’s Medical Solutions Division today announced its 3M™ V.A.C.® Therapy negative
Read MoreCSafe joins BioLife’s global partner network of cold chain solution providers using the evo® cold chain management platform MONROE, Ohio
Read MoreSINGAPORE, Sept. 15, 2022 /PRNewswire/ — GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK) and GenScriptProBio (a global one-stop CDMO from GenScript
Read More